Despite a robust performance in the ID vertical and new business contributions, Valid Solucoes SA faces hurdles in the pay segment and year-over-year revenue growth.

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

Third quarter 2025 net revenues were $17.6 million Emrosi total prescriptions increased 146% over the second quarter of 2025 Emrosi net revenues were $4.9 million Company to hold conference call today ...

Why is the revoking of 14 quality control orders (QCOs) on intermediate goods affecting textile value chain important for ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken ...